News
Zevtera, an advanced-generation cephalosporin, is available for treating Staphylococcus aureus bacteremia and 2 other types ...
Staphylococcus aureus is a pathogen commonly involved in the etiology of nosocomial and community-acquired infections. This microorganism adheres and forms biofilm on biotic and abiotic surfaces, ...
1d
Zacks Investment Research on MSNARMP Soars 72% in a Month Following Infectious Disease Study SuccessArmata Pharmaceuticals ARMP shares have skyrocketed 72.3% in the past month. The massive surge in the stock price was ...
Basilea Pharmaceutica announces commercial availability of antibiotic Zevtera in United States: Allschwil, Switzerland Wednesday, May 21, 2025, 11:00 Hrs [IST] Basilea Pharmaceuti ...
Basilea announces commercial availability of antibiotic Zevtera® (ceftobiprole) in the United States
Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs ...
Staphylococcus aureus bacteremia (SAB) is a serious bloodstream infection associated with significant morbidity and mortality.(3) Complications ...
Hospitalists play a crucial role in combating hospital-acquired infections. Learn about the strategies that are proving to be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results